Gastrinoma Diagnosis and Management

Clinical Presentation and Diagnostic Approach

The National Comprehensive Cancer Network recommends suspecting gastrinoma in patients with severe gastroduodenal ulcer symptoms accompanied by diarrhea, particularly when peptic ulcers are recurrent and occur in the absence of Helicobacter pylori infection 1, 2
Recurrent peptic ulcer disease with or without gastrointestinal bleeding is a classic clinical feature of gastrinoma 3, 4, 5
Chronic diarrhea often precedes ulcer symptoms in patients with gastrinoma 1, 2
Evaluate for Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome in all patients with suspected gastrinoma, as gastrinoma is one of the most common pancreatic neuroendocrine tumors in MEN1 patients 1, 6, 2, 5

Measure fasting serum gastrin levels after discontinuing PPIs for at least 1 week, as this is the most critical step in diagnosing gastrinoma 1, 3, 4, 2, 7
Fasting gastrin >10 times upper limit of normal plus gastric pH <2 is diagnostic of gastrinoma 2
Secretin stimulation test should be performed in equivocal cases 1, 3, 4, 5
Upper gastrointestinal endoscopy with gastric biopsy is always required to differentiate gastrinoma from autoimmune atrophic gastritis 3, 4, 5

Most gastrinomas (approximately 70%) are located in the duodenum, not the pancreas 3, 4, 5
Duodenal gastrinomas are typically small and may be multiple in MEN1 patients 1
80-90% of gastrinomas have metastatic potential 6, 2

Do not interpret gastrin levels while patient is on PPIs or H2 antagonists, as this is the most common cause of diagnostic error 1, 3, 4, 2, 7
Do not assume all elevated gastrin is gastrinoma, as achlorhydria and atrophic gastritis are far more common causes 1, 2